| Synonyms: | |
| Status: | Approved (1946) |
| Entry Type: | Small molecule |
| Molecule Category: | UNKNOWN |
| UNII: | W53L6FE61V |
| InChI Key | UNBRKDKAWYKMIV-QWQRMKEZSA-N |
|---|---|
| Smile | |
| InChI |
|
| Property Name | Value |
|---|---|
| Molecular Formula | C20H25N3O2 |
| Molecular Weight | 339.44 |
| AlogP | 1.92 |
| Hydrogen Bond Acceptor | 3.0 |
| Hydrogen Bond Donor | 3.0 |
| Number of Rotational Bond | 4.0 |
| Polar Surface Area | 68.36 |
| Molecular species | NEUTRAL |
| Aromatic Rings | 2.0 |
| Heavy Atoms | 25.0 |
| Targets | EC50(nM) | IC50(nM) | Kd(nM) | Ki(nM) | Inhibition(%) | |
|---|---|---|---|---|---|---|
|
Enzyme
Hydrolase
|
- | - | - | - | ||
|
Membrane receptor
Family A G protein-coupled receptor
Small molecule receptor (family A GPCR)
Monoamine receptor
Serotonin receptor
|
21 | - | - | 1 | - | |
|
Transporter
Electrochemical transporter
SLC superfamily of solute carriers
SLC47 family of multidrug and toxin extrusion transporters
|
- | - | - | - | 12 |
| Mesh Heading | Maximum Phase | Reference |
|---|---|---|
| Hemorrhage; Uterine Inertia | Phase 4 | ClinicalTrials |
| Hemorrhage; Postpartum Hemorrhage; Uterine Inertia | Early Phase 1 | ClinicalTrials |
| Resources | Reference |
|---|---|
| CAS NUMBER | 113-42-8 |
| ChEBI | 92607 |
| ChEMBL | CHEMBL1201356 |
| DrugBank | DB00353 |
| DrugCentral | 1764 |
| EPA CompTox | DTXSID1023283 |
| FDA SRS | W53L6FE61V |
| Human Metabolome Database | HMDB0014497 |
| Guide to Pharmacology | 150 |
| PDB | H8D |
| PharmGKB | PA450461 |
| PubChem | 8226 |
| SureChEMBL | SCHEMBL78176 |
| ZINC | ZINC000095619105 |